Quantbot Technologies LP Liva Nova PLC Transaction History

Quantbot Technologies LP

$3.24 Billion
Q3 2025

A detailed history of Quantbot Technologies LP transactions in Liva Nova PLC stock. As of the latest transaction made, Quantbot Technologies LP holds 22,689 shares of LIVN stock, worth $1.26 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

22,689

Previous 30,600 25.85%

Holding current value

$1.26 Million

Previous $1.38 Million 13.73%

% of portfolio

0.04%

Previous 0.04%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 12, 2025	SELL	$41.13 - $58.72 $325,379 - $464,533	-7,911 Reduced 25.85%	22,689 $1.19 Million
Q2 2025 Aug 13, 2025	BUY	$33.85 - $47.6 $1.04 Million - $1.46 Million	30,600 New	30,600 $1.38 Million
Q4 2024 Feb 11, 2025	SELL	$45.7 - $53.85 $1.15 Million - $1.36 Million	-25,215 Reduced 66.78%	12,546 $581,000
Q3 2024 Nov 13, 2024	BUY	$43.38 - $54.59 $1.64 Million - $2.06 Million	37,761 New	37,761 $1.98 Million
Q1 2024 May 06, 2024	BUY	$48.6 - $57.12 $863,962 - $1.02 Million	17,777 New	17,777 $994,000

Q2 2023 Aug 08, 2023	SELL	$42.28 - $51.43 $651,661 - $792,690	-15,413 Reduced 98.61%	218 $11,000
Q1 2023 May 12, 2023	BUY	$40.84 - $58.14 $638,370 - $908,786	15,631 New	15,631 $681,000
Q1 2019 May 13, 2019	SELL	$86.15 - $100.49 $228,814 - $266,901	-2,656 Closed	0 $0
Q4 2018 Feb 13, 2019	SELL	$84.14 - $125.42 $786,120 - $1.17 Million	-9,343 Reduced 77.86%	2,656 $242,000
Q3 2018 Nov 13, 2018	BUY	$101.02 - $130.95 $1.21 Million - $1.57 Million	11,999 New	11,999 $1.49 Million

Others Institutions Holding LIVN

# of Institutions

296

Shares Held

56.9M

Call Options Held

152K

Put Options Held

49.3K

View Full List

About LivaNova PLC

Ticker LIVN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 53,545,700
Market Cap $2.96B
Description
LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. It operates through three segments: Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines,...

More about LIVN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

News

Stay updated on Quantbot Technologies LP with notifications on news.

Account

Quantbot Technologies LP Liva Nova PLC Transaction History